Roche turns to DM to boost patient compliance with its weight loss drug.
It can be tough getting patients to take their medicines as prescribed, particularly when there are side-effects or other barriers involved. To get around this problem, Roche decided to develop a DM approach to guide patients taking the organization's new weight-loss agent, XENICAL. In place now for 15 months, the telephonic program is boosting compliance and getting the intended results.